The global diabetes therapeutics industry was estimated at $1.3B in 2020, and is anticipated to hit $3.4B by 2030, registering a CAGR of 10.4% from 2021 to 2030, according to the Allied Market Research report “Diabetes Therapeutics Market”.
Growth drivers include the surge in the prevalence of diabetes, rise in sedentary lifestyle, and increase in incidences of other chronic diseases such as hypertension
At the same time, a surge in awareness among the population about self-management of diabetes has supplemented the market growth yet more. Furthermore, development of affordable and effective diabetes therapeutics such as oral hypoglycemic agents and several government initiatives to provide diabetes care facilities are expected to create lucrative opportunities in the industry.
https://www.alliedmarketresearch.com/request-sample/3542